Farydak Now Approved Sep 20, 2015Sep 25, 2015 Brand: Farydak (panobinostat), Capsules Parent Company: Novartis Drug Type: Boxed Warning Drug Category: Oncology Campaign: now-approved Targeting: HCPs, Patients Patient Website: https://www.us.farydak.com/ HCP Website: https://www.hcp.novartis.com/products/farydak/multiple-myeloma/ Patient Homepage Patient Homepage on Mobile Patient Menu on Mobile Patient Level 2 Page HCP Homepage HCP Menu on Mobile HCP Registration Form REMS Site